Medicine and Dentistry
Adenocarcinoma
9%
Anal Cancer
11%
Arm
10%
Biological Marker
28%
Brain Metastasis
8%
Cancer
10%
Cancer Therapy
8%
Chemoradiotherapy
33%
Cholangiocarcinoma
26%
Clinical Trial
9%
Computer Assisted Tomography
36%
Diseases
27%
Gemcitabine
12%
Hazard Ratio
11%
Hepatocellular Carcinoma
41%
Image-Guided Intervention
9%
Immunotherapy
7%
Intensity Modulated Radiation Therapy
14%
Intraductal Papillary Mucinous Tumor
11%
Magnetic Resonance Imaging
10%
Malignant Neoplasm
24%
Metastatic Carcinoma
14%
Neoadjuvant Therapy
15%
Neoplasm
76%
Oncology
13%
Overall Survival
56%
Paclitaxel
11%
Pancreas Adenocarcinoma
79%
Pancreas Cancer
81%
Pancreatectomy
11%
Pancreaticoduodenectomy
14%
Patient-Reported Outcome
7%
Pelvis
13%
Progression Free Survival
9%
Proportional Hazards Model
8%
Proton Therapy
13%
Quality of Life
10%
Radiation Oncology
11%
Radiation Therapy
100%
Radiomics
10%
Re-Irradiation
11%
Rectum Cancer
10%
Rectum Carcinoma
7%
Recurrent Disease
10%
Solid Malignant Neoplasm
8%
Squamous Cell Carcinoma
8%
Stereotactic Body Radiation Therapy
28%
Surgery
25%
Survival Rate
7%
Systemic Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Duct Carcinoma
8%
Biological Marker
16%
Breast Cancer
5%
Chemoradiation Therapy
24%
Chemotherapy
28%
Clinical Trial
8%
Diseases
13%
Dosimetry
5%
Gemcitabine
11%
Immune Checkpoint Inhibitor
7%
Immunotherapy
5%
Liver Cancer
6%
Liver Cell Carcinoma
26%
Malignant Neoplasm
22%
Neoplasm
44%
Overall Survival
34%
Paclitaxel
16%
Pancreas Adenocarcinoma
32%
Pancreas Cancer
38%
Progression Free Survival
7%
Recurrent Disease
6%
Solid Malignant Neoplasm
6%
Squamous Cell Carcinoma
7%
Vascular Tumor
5%
Keyphrases
Chemoradiation
9%
Chemotherapy
7%
Hepatocellular Carcinoma
15%
Imaging Biomarkers
6%
Intrahepatic Cholangiocarcinoma (iCCA)
15%
Liver
6%
Locally Advanced
5%
Overall Survival
11%
Pancreatic Cancer
15%
Pancreatic Ductal Adenocarcinoma
19%
Pancreaticoduodenectomy
6%
Radiation Therapy
20%
Radiotherapy
14%
Resectable Pancreatic Cancer
6%
Systemic Therapy
7%
Tumor
11%
United States
6%